Skip to content

A single-center, prospective cohort study on the progression of postoperative cognitive dysfunction in elderly patients with cognitive frailty

A single-center, prospective cohort study on the progression of postoperative cognitive dysfunction in elderly patients with cognitive frailty

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043475
Enrollment
Unknown
Registered
2021-02-19
Start date
2021-02-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Cognitive frailty group:No
Cognitive normal group:No

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Without anesthesia drug allergy history; 2. Always inadvertently cerebrovascular disease or related operation history; 3. Without neurological or mental illness; 4. Without taking antipsychotic drugs for a long time or history of antidepressant drugs. 5. No alcohol dependence or substance abuse: no hearing and speech disorders; 6. Simple mental state scale score higher than the corresponding cultural level of the lowest score: illiteracy (not education) or greater 17 points, primary school education (education duration of less than or equal to 6 years) 20 points or higher, secondary school or above education (education duration of more than 6 years) or greater 23 points.

Exclusion criteria

Exclusion criteria: 1. Ruled out the use immune inhibitors or immunomodulatory therapy; 2. Known to influence cognitive function of chemotherapy drugs; 3. In cognitive tests during severe head trauma or undergoing chemotherapy; 4. Don't participate in neuropsychological testing or during perioperative MRI inspectors; 5. Patients transferred to intensive care unit (ICU) after operation 6. Such as postoperative cerebral embolism, cerebral hemorrhage, pulmonary infection patients with serious complications

Design outcomes

Primary

MeasureTime frame
Cognitive assessment scales;

Secondary

MeasureTime frame
Head MRI;Biochemical factors associatedactors associated;

Countries

China

Contacts

Public ContactJianhui Liu

Shanghai Tongji Hospital

jianhuiliu_1246@163.com+86 13661452939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026